|
Name
|
DA-related behavior
|
Gating
|
Cognitive behavior
|
Social behavior
|
Molecular morphological signature
|
Response to APD
|
|
Neonatal NGF-Induced Frontal Cortex Lesion
|
Hyperactivity
|
|
|
Social interaction deficit
|
|
|
|
Neonatal Ventral Hippocampal Lesion
|
Enhanced locomotor responses to amphetamine with
post-pubertal onset; enhanced meth-amphetamine
self-administration
|
Disrupted PPI; prolonged N40 latency
|
Various impairments in learning and memory (including
set-shifting and spatial working memory)
|
Impaired social behavior
|
Reduced presynaptic protein and growth factor expression,
reduced NMDA receptor expression, impaired DA receptor
expression in frontal cortex; impaired maturation of PFC;
brain region- and age-specific changes in GABAA receptor
expression; reduced PFC spine density; enhanced sensitivity
to nicotine; increased prefrontal DA output
|
Locomotor responses blocked by APD, social impairments
blocked by clozapine but not haloperidol; clozapine
reversed enhanced novelty-induced locomotor activity and
rescued neuronal atrophy in the prefrontal cortex and
nucleus accumbens
|
|
Neonatal Amygdalar Lesion
|
Enhanced amphetamine or apomorphine induced locomotion;
increased novelty induced locomotor activity
|
Increased acoustic startle response but impair PPI on
animals lesioned on PND 7 but not PND 21; abnormally
persistent latent inhibition
|
Impaired place navigation and spatial ability (not found by
all studies); impaired spatial alternation and food hoarding
|
Social behaviors diminished in animals lesioned on PND 7 but
not 21 but ventral HPC lesions did not affect social behavior
|
Increased lateral ventricular volume; reduced density of D1-
and D2-like but not D3-like receptors and increased DA
turnover in mesolimbic but not striatal regions; decreased
spine density in the prefrontal cortex and nucleus accumbens
|
|